1. Home
  2. ENTO vs BSFC Comparison

ENTO vs BSFC Comparison

Compare ENTO & BSFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTO
  • BSFC
  • Stock Information
  • Founded
  • ENTO 2014
  • BSFC 1995
  • Country
  • ENTO United States
  • BSFC United States
  • Employees
  • ENTO N/A
  • BSFC N/A
  • Industry
  • ENTO Biotechnology: Pharmaceutical Preparations
  • BSFC
  • Sector
  • ENTO Health Care
  • BSFC
  • Exchange
  • ENTO Nasdaq
  • BSFC Nasdaq
  • Market Cap
  • ENTO 1.2M
  • BSFC 1.2M
  • IPO Year
  • ENTO 2016
  • BSFC N/A
  • Fundamental
  • Price
  • ENTO $0.45
  • BSFC $0.23
  • Analyst Decision
  • ENTO
  • BSFC
  • Analyst Count
  • ENTO 0
  • BSFC 0
  • Target Price
  • ENTO N/A
  • BSFC N/A
  • AVG Volume (30 Days)
  • ENTO 195.4K
  • BSFC 2.2M
  • Earning Date
  • ENTO 11-13-2024
  • BSFC 11-14-2024
  • Dividend Yield
  • ENTO N/A
  • BSFC N/A
  • EPS Growth
  • ENTO N/A
  • BSFC N/A
  • EPS
  • ENTO N/A
  • BSFC N/A
  • Revenue
  • ENTO N/A
  • BSFC $5,930,019.00
  • Revenue This Year
  • ENTO N/A
  • BSFC $454.59
  • Revenue Next Year
  • ENTO N/A
  • BSFC N/A
  • P/E Ratio
  • ENTO N/A
  • BSFC N/A
  • Revenue Growth
  • ENTO N/A
  • BSFC N/A
  • 52 Week Low
  • ENTO $0.19
  • BSFC $0.20
  • 52 Week High
  • ENTO $14.51
  • BSFC $8.90
  • Technical
  • Relative Strength Index (RSI)
  • ENTO 41.13
  • BSFC 30.69
  • Support Level
  • ENTO $0.38
  • BSFC $0.20
  • Resistance Level
  • ENTO $0.68
  • BSFC $0.24
  • Average True Range (ATR)
  • ENTO 0.07
  • BSFC 0.04
  • MACD
  • ENTO -0.03
  • BSFC 0.00
  • Stochastic Oscillator
  • ENTO 21.82
  • BSFC 17.76

About ENTO Entero Therapeutics Inc. Common Stock

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address significant unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

About BSFC Blue Star Foods Corp.

Blue Star Foods Corp is an international seafood company based in Miami. It imports, packages, and sells refrigerated pasteurized crab meat, and other premium seafood products. The company derives revenue from importing blue and red swimming crab meat from Indonesia, Philippines and China and distributing it in the United States and Canada under several premium brand names such as Blue Star, Oceanica, Pacifika, Crab & Go, First Choice, Good Stuff and Coastal Pride Fresh and TOBC steelhead salmon and rainbow trout fingerlings produced under the brand name Little Cedar Falls.. The Company's products are sold in the United States and Canada.

Share on Social Networks: